We are monitoring the impact of COVID-19 on Europe Haemostatic Agents Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4373
Share on
Share on

Europe Haemostatic Agents Market Research Report – Segmented By Type, Treatment, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4373
Pages: 185

Europe Haemostatic Agents Market Size (2020 to 2025)

The size of the Haemostatic Agents Market in the Europe is estimated to grow at a robust CAGR from 2020 to 2025.

Haemostatic Agents refers to the class of substances that are usually used to promote haemostasis or to stop bleeding. Haemostats are the technical term given to instruments used to reduce or halt bleeding during a surgical procedure.

The major technological advancements in the field have increased the usage of haemostats in surgical procedures in recent times. Common problems faced by haemostats include tissue contamination and ease of usage. These have been addressed in the latest wave of innovations

The major factors affecting the Haemostatic Agents market include the rising prevalence of diseases and rising awareness regarding latest medical practices. Other drivers include increasing health consciousness among consumers, use of new inventions and enhanced technologies. As for the restraints of the market, the high costs and the unfavourable reimbursement policies are the major hurdles. This along with the fact that people are not aware of the latest developments in developing and underdeveloped countries restrain the market growth.

This research report on the Europe Haemostatic Agents Market has been segmented and sub-segmented into the following categories:

  • By Type: Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants and Others
  • By Treatment: Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery and Others      
  • By End User: Hospitals, Surgery Centres, Nursing Homes and Others      
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe

Regionally, the European region has the second highest market share globally only behind the likes of North America, albeit with a low CAGR rate. The low growth rate of the region can be attributed to the fact that most countries in the region are in their pinnacle of development and the room to grow is fast decreasing.

Some of the key companies leading the European Haemostatic Agents Market profiled in this report are Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies and Z-Medica.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  2. Europe Thrombin Based Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Gelatin Based Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Collagen Based Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Oxidized Regenerated Cellulose Based Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Combination Haemostats Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Fibrin Sealants Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  10. Europe Cardiovascular Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe General Surgery Market, By Region, From 2020 to 2025 (USD Million)
  12. Europe Digestive Surgery Market, By Region, From 2020 to 2025 (USD Million)
  13. Europe Neurosurgery Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  15. Europe Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  16. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  17. Europe Surgery Centres Market, By Region, From 2020 to 2025 (USD Million)
  18. Europe Nursing Homes Market, By Region, From 2020 to 2025 (USD Million)
  19. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  20. U.K. Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  21. U.K. Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  22. U.K. Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  23. Germany Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  24. Germany Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  25. Germany Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  26. France Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  27. France Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  28. France Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  29. Italy Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  30. Italy Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  31. Italy Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)
  32. Spain Haemostatic Agents Market, By Type, From 2020 to 2025 (USD Million)
  33. Spain Haemostatic Agents Market, By Treatment, From 2020 to 2025 (USD Million)
  34. Spain Haemostatic Agents Market, By End Users, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample